354 related articles for article (PubMed ID: 23462619)
1. The Citrobacter rodentium mouse model: studying pathogen and host contributions to infectious colitis.
Bhinder G; Sham HP; Chan JM; Morampudi V; Jacobson K; Vallance BA
J Vis Exp; 2013 Feb; (72):e50222. PubMed ID: 23462619
[TBL] [Abstract][Full Text] [Related]
2. Investigation of Host and Pathogen Contributions to Infectious Colitis Using the Citrobacter rodentium Mouse Model of Infection.
Bosman ES; Chan JM; Bhullar K; Vallance BA
Methods Mol Biol; 2016; 1422():225-41. PubMed ID: 27246037
[TBL] [Abstract][Full Text] [Related]
3. Citrobacter rodentium: infection, inflammation and the microbiota.
Collins JW; Keeney KM; Crepin VF; Rathinam VA; Fitzgerald KA; Finlay BB; Frankel G
Nat Rev Microbiol; 2014 Sep; 12(9):612-23. PubMed ID: 25088150
[TBL] [Abstract][Full Text] [Related]
4. Preinoculation with the probiotic Lactobacillus acidophilus early in life effectively inhibits murine Citrobacter rodentium colitis.
Chen CC; Louie S; Shi HN; Walker WA
Pediatr Res; 2005 Dec; 58(6):1185-91. PubMed ID: 16306191
[TBL] [Abstract][Full Text] [Related]
5. Dietary vitamin D3 deficiency alters intestinal mucosal defense and increases susceptibility to Citrobacter rodentium-induced colitis.
Ryz NR; Lochner A; Bhullar K; Ma C; Huang T; Bhinder G; Bosman E; Wu X; Innis SM; Jacobson K; Vallance BA
Am J Physiol Gastrointest Liver Physiol; 2015 Nov; 309(9):G730-42. PubMed ID: 26336925
[TBL] [Abstract][Full Text] [Related]
6. Intestinal Epithelial Cells and the Microbiome Undergo Swift Reprogramming at the Inception of Colonic Citrobacter rodentium Infection.
Hopkins EGD; Roumeliotis TI; Mullineaux-Sanders C; Choudhary JS; Frankel G
mBio; 2019 Apr; 10(2):. PubMed ID: 30940698
[TBL] [Abstract][Full Text] [Related]
7. Utility of the Citrobacter rodentium infection model in laboratory mice.
Borenshtein D; McBee ME; Schauer DB
Curr Opin Gastroenterol; 2008 Jan; 24(1):32-7. PubMed ID: 18043230
[TBL] [Abstract][Full Text] [Related]
8. Bacterial Adrenergic Sensors Regulate Virulence of Enteric Pathogens in the Gut.
Moreira CG; Russell R; Mishra AA; Narayanan S; Ritchie JM; Waldor MK; Curtis MM; Winter SE; Weinshenker D; Sperandio V
mBio; 2016 Jun; 7(3):. PubMed ID: 27273829
[TBL] [Abstract][Full Text] [Related]
9. The Mouse Model of Infection with Citrobacter rodentium.
Bouladoux N; Harrison OJ; Belkaid Y
Curr Protoc Immunol; 2017 Nov; 119():19.15.1-19.15.25. PubMed ID: 29091261
[TBL] [Abstract][Full Text] [Related]
10. Saccharomyces boulardii ameliorates Citrobacter rodentium-induced colitis through actions on bacterial virulence factors.
Wu X; Vallance BA; Boyer L; Bergstrom KS; Walker J; Madsen K; O'Kusky JR; Buchan AM; Jacobson K
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G295-306. PubMed ID: 18032474
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor 4 contributes to colitis development but not to host defense during Citrobacter rodentium infection in mice.
Khan MA; Ma C; Knodler LA; Valdez Y; Rosenberger CM; Deng W; Finlay BB; Vallance BA
Infect Immun; 2006 May; 74(5):2522-36. PubMed ID: 16622187
[TBL] [Abstract][Full Text] [Related]
12. Concurrent infection with an intestinal helminth parasite impairs host resistance to enteric Citrobacter rodentium and enhances Citrobacter-induced colitis in mice.
Chen CC; Louie S; McCormick B; Walker WA; Shi HN
Infect Immun; 2005 Sep; 73(9):5468-81. PubMed ID: 16113263
[TBL] [Abstract][Full Text] [Related]
13. Specialized Proresolving Mediators Rescue Infant Mice from Lethal Citrobacter rodentium Infection and Promote Immunity against Reinfection.
Diaz LA; Altman NH; Khan WN; Serhan CN; Adkins B
Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28694292
[TBL] [Abstract][Full Text] [Related]
14. Galactooligosaccharide supplementation provides protection against Citrobacter rodentium-induced colitis without limiting pathogen burden.
Kittana H; Quintero-Villegas MI; Bindels LB; Gomes-Neto JC; Schmaltz RJ; Segura Munoz RR; Cody LA; Moxley RA; Hostetter J; Hutkins RW; Ramer-Tait AE
Microbiology (Reading); 2018 Feb; 164(2):154-162. PubMed ID: 29256851
[TBL] [Abstract][Full Text] [Related]
15. Citrobacter rodentium-induced colitis: A robust model to study mucosal immune responses in the gut.
Koroleva EP; Halperin S; Gubernatorova EO; Macho-Fernandez E; Spencer CM; Tumanov AV
J Immunol Methods; 2015 Jun; 421():61-72. PubMed ID: 25702536
[TBL] [Abstract][Full Text] [Related]
16. TLR9 limits enteric antimicrobial responses and promotes microbiota-based colonisation resistance during Citrobacter rodentium infection.
Yang H; Yu HB; Bhinder G; Ryz NR; Lee J; Yang H; Fotovati A; Gibson DL; Turvey SE; Reid GS; Vallance BA
Cell Microbiol; 2019 Jul; 21(7):e13026. PubMed ID: 30893495
[TBL] [Abstract][Full Text] [Related]
17.
Krekhno Z; Woodward SE; Serapio-Palacios A; Peña-Díaz J; Moon KM; Foster LJ; Finlay BB
Gut Microbes; 2024; 16(1):2308049. PubMed ID: 38299318
[TBL] [Abstract][Full Text] [Related]
18. Citrobacter rodentium Infection Model for the Analysis of Bacterial Pathogenesis and Mucosal Immunology.
Kennedy CL; Hartland EL
Methods Mol Biol; 2018; 1725():77-89. PubMed ID: 29322410
[TBL] [Abstract][Full Text] [Related]
19. Card9 mediates susceptibility to intestinal pathogens through microbiota modulation and control of bacterial virulence.
Lamas B; Michel ML; Waldschmitt N; Pham HP; Zacharioudaki V; Dupraz L; Delacre M; Natividad JM; Costa GD; Planchais J; Sovran B; Bridonneau C; Six A; Langella P; Richard ML; Chamaillard M; Sokol H
Gut; 2018 Oct; 67(10):1836-1844. PubMed ID: 28790160
[TBL] [Abstract][Full Text] [Related]
20. Epithelial talin-1 protects mice from
Latour YL; Allaman MM; Barry DP; Smith TM; Williams KJ; McNamara KM; Jacobse J; Goettel JA; Delgado AG; Piazuelo MB; Zhao S; Gobert AP; Wilson KT
Gut Microbes; 2023; 15(1):2192623. PubMed ID: 36951501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
